Skip to Content
American Heart Association
Sign-in / Sign-up
Join or Renew
My Local Events
Find out what is happening at your local American Heart
Have an account?
Need an account?
Login with Your Social Identity:
Statements & Guidelines
FDA approves evolocumab, a PCSK9 inhibitor, to treat certain patients with high cholesterol
Exercise Training for Type 2 Diabetes
Exercise Training for Type 2 Diabetes – Impact on Cardiovascular Risk
Type 2 diabetes (T2DM) is the sixth leading cause of death with nearly 70 percent of deaths attributed to cardiovascular disease
The economic cost of T2DM in the United States is an estimated $172 billion.
To improve cardiac risk, patients with T2DM should participate in exercise.
Read full article in
AHA Physical Activity Guidelines
Physical Activity Guidelines For Americans
Professional Online Network
JOIN OUR NETWORK
Already in the network?